Anglo-Saxon guidelines for the treatment of community-acquired pneumonia applicable in the Netherlands as well;Angelsaksische richtlijnen voor de behandeling van thuis opgelopen pneumonie ook in Nederland toepasbaar

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 33, 1997, Pages 1597-1601

  Hoepelman, I M ^a   Sachs, A P E ^a   Visser, M R ^a   Lammers, J W J ^a  

^a Sector Neuropsychologie V K   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; CILASTATIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; MACROLIDE; PENICILLIN G; TETRACYCLINE;

CHLAMYDOPHILA PNEUMONIAE; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LEGIONELLA PNEUMOPHILA; MYCOPLASMA PNEUMONIAE; NETHERLANDS; PNEUMONIA; PRACTICE GUIDELINE; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MIDDLE AGED; PNEUMONIA; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC;

EID: 0030749946     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association Am Rev Respir Dis 1993;148: 1418-26.
2. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society. Br J Hosp Med 1993;49:346-50.
3. Mandell LA, Niederman M. The Canadian Community Acquired Pneumonia Consensus Conference Group. Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Can J Infect Dis 1993;4:25-8
4. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;333:1618-24.
5. Marrie TJ, Peeling RW, Fine MJ, Singer DE, Loley CM, Kapoor WN. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course Am J Med 1996, 101:508-15.
6. Hoepelman IM. Diagnosis and chemotherapy of Legionnaires' disease. Neth J Med 1996;49:185-8.
7. Bohte R, Hermans J, Broek PJ van den. Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia. Eur J Microbiol Infect Dis 1996,15:201-5
8. Roord JJ, Wolf BH, Gossens MM, Kimpen JL. Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. Antimicrob Agents Chemother 1996;40:2765-8.
9. Hoepelman IM, Schneider MME. Azithromycin. the first of the tissue selective azalides. Int J Antimicrob Agents 1995;5:145-67.
10. Anderson G, Esmonde TS, Coles S, Macklin J, Carnegie C. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia. J Antimicrob Chemother 1991;27(suppl A):117-24.
11. Bohte R, Wout JW van 't, Lobatto S, Blusse van Oud Alblas A, Boekhout M, Nauta EH, et al. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 1995;14:182-7.
12. The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service. Respir Med 1992;86:7-13.
13. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P. Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Chest 1994;105:1487-95.
14. Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier JM, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995;21:24-31.
15. Mundy LM, Auwaerter PG, Oldach D, Warner ML, Burton A, Vance E. et al. Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med 1995;152(4 Pt 1):1039-15.
16. Neeling AJ, Hemmes JH, Klingeren B van. Resistentie tegen antibiotica bij routine-isolaten van bacterien in zeven streeklaboratoria. Rapportnr 253601001. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu, 1993 (aanvulling 1995).
17. Hoepelman IM, Verhoef J. Nieuwe macroliden, azaliden en streptograminen: de huidige plaats en hun toekomstperspectief. Ned Tijdschr Geneeskd 1992;136:1847-51.
18. Janknegt R, Wijnands WJ, Stobberingh EE. Antibiotic policies in Dutch hospitals for the treatment of pneumonia. J Antimicrob Chemother 1994;34:431-42.